Ulf Meier-Kriesche

Chief Tech/Sci/R&D Officer at VELOXIS PHARMACEUTICALS A/S

Health Technology

Consumer Services

Profile

Ulf Meier-Kriesche is currently the Chief Scientific Officer at Veloxis Pharmaceuticals A since 2017.
He obtained a doctorate degree from the University of Perugia.

Ulf Meier-Kriesche active positions

Companies	Position	Start
VELOXIS PHARMACEUTICALS A/S	Chief Tech/Sci/R&D Officer	2017-09-12

All active positions of Ulf Meier-Kriesche

Training of Ulf Meier-Kriesche

University of Perugia

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ulf Meier-Kriesche's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.	Health Technology